Healthcare Innovations, 4

Back to All Secondary Trusts

Portfolio Holdings by Security (As of Deposit Date)

  • Ticker
    Security Description
    Deposit %
  • ACAD
    ACADIA Pharmaceuticals Inc.
    3.27
  • AERI
    Aerie Pharmaceuticals, Inc.
    3.32
  • AGIO
    Agios Pharmaceuticals, Inc.
    3.40
  • ALNY
    Alnylam Pharmaceuticals, Inc.
    3.56
  • ALXN
    Alexion Pharmaceuticals, Inc.
    3.38
  • ARRY
    Array BioPharma Inc.
    3.31
  • BGNE
    BeiGene, Ltd.
    3.54
  • BLUE
    bluebird bio, Inc.
    3.55
  • CLVS
    Clovis Oncology, Inc.
    3.44
  • DBVT
    DBV Technologies S.A.
    3.33
  • DERM
    Dermira, Inc.
    3.49
  • ENDP
    Endo International plc
    3.21
  • FGEN
    FibroGen, Inc.
    3.57
  • GBT
    Global Blood Therapeutics, Inc.
    3.20
  • GWPH
    GW Pharmaceuticals plc
    3.35
  • HALO
    Halozyme Therapeutics, Inc.
    4.06
  • HZNP
    Horizon Pharma plc
    3.01
  • ICPT
    Intercept Pharmaceuticals, Inc.
    2.48
  • IRWD
    Ironwood Pharmaceuticals, Inc.
    3.45
  • JAZZ
    Jazz Pharmaceuticals plc
    3.36
  • LGND
    Ligand Pharmaceuticals Incorporated
    3.32
  • LOXO
    Loxo Oncology, Inc.
    3.77
  • MDCO
    The Medicines Company
    3.02
  • NBIX
    Neurocrine Biosciences, Inc.
    3.29
  • NKTR
    Nektar Therapeutics
    3.30
  • PBYI
    Puma Biotechnology, Inc.
    3.25
  • PCRX
    Pacira Pharmaceuticals, Inc.
    3.39
  • SAGE
    Sage Therapeutics, Inc.
    2.48
  • SUPN
    Supernus Pharmaceuticals, Inc.
    3.38
  • XLRN
    Acceleron Pharma Inc.
    3.52

Health Care

  • Ticker
    Security Description
    Deposit %
  • ACAD
    ACADIA Pharmaceuticals Inc.
    3.27
  • XLRN
    Acceleron Pharma Inc.
    3.52
  • AERI
    Aerie Pharmaceuticals, Inc.
    3.32
  • AGIO
    Agios Pharmaceuticals, Inc.
    3.40
  • ALXN
    Alexion Pharmaceuticals, Inc.
    3.38
  • ALNY
    Alnylam Pharmaceuticals, Inc.
    3.56
  • ARRY
    Array BioPharma Inc.
    3.31
  • BGNE
    BeiGene, Ltd.
    3.54
  • BLUE
    bluebird bio, Inc.
    3.55
  • CLVS
    Clovis Oncology, Inc.
    3.44
  • DBVT
    DBV Technologies S.A.
    3.33
  • DERM
    Dermira, Inc.
    3.49
  • ENDP
    Endo International plc
    3.21
  • FGEN
    FibroGen, Inc.
    3.57
  • GBT
    Global Blood Therapeutics, Inc.
    3.20
  • GWPH
    GW Pharmaceuticals plc
    3.35
  • HALO
    Halozyme Therapeutics, Inc.
    4.06
  • HZNP
    Horizon Pharma plc
    3.01
  • ICPT
    Intercept Pharmaceuticals, Inc.
    2.48
  • IRWD
    Ironwood Pharmaceuticals, Inc.
    3.45
  • JAZZ
    Jazz Pharmaceuticals plc
    3.36
  • LGND
    Ligand Pharmaceuticals Incorporated
    3.32
  • LOXO
    Loxo Oncology, Inc.
    3.77
  • MDCO
    The Medicines Company
    3.02
  • NKTR
    Nektar Therapeutics
    3.30
  • NBIX
    Neurocrine Biosciences, Inc.
    3.29
  • PCRX
    Pacira Pharmaceuticals, Inc.
    3.39
  • PBYI
    Puma Biotechnology, Inc.
    3.25
  • SAGE
    Sage Therapeutics, Inc.
    2.48
  • SUPN
    Supernus Pharmaceuticals, Inc.
    3.38

Summary

Description

  • Trust Name

    Healthcare Innovations, 4

  • Trust Symbol

    SMHCDX

Deposit Data

  • Deposit Date

    11-01-2017

  • Termination Date

    11-01-2019

  • Minimum Investment

    100

  • Distribution Frequency

    Monthly (if any)

  • Initial Public Offer Price

    $10.00

  • Historical 12-Month Dist.*

    0.00

CUSIP

  • Cash Cusip

    83188M101

  • Reinvest Cusip

    83188M119

  • Fee Cash Cusip

    83188M127

  • Fee Invest Cusip

    83188M135

*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.